Genetically modified herpes virus delivers one-two punch against advanced cancers 22 Sep 2022 A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial. Find out more Show/Hide
New combination therapy exploits ‘natural killer’ cells to destroy head and neck tumours 16 Jun 2022 Scientists have identified a new treatment combination that is highly effective at suppressing the growth of head and neck tumours. Find out more Show/Hide
ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers 14 Jun 2022 Discovery Club members gathered at the Science Museum in London to learn how our researchers are transforming cancer care for patients with innovative combination therapies. Find out more Show/Hide
New head and neck cancer radiotherapy technique could deliver more robust treatment plan in shorter time on MR Linac 23 May 2022
ESMO 2021: Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers 11 Oct 2021